Advertisement

Effects of Some Growth Factors and Cytokines on the Expression of the Repair Enzyme MGMT and Protein MARP in Human Cells In Vitro

Effect of Some Growth Factors and Cytokines
  • Kateryna Kotsarenko
  • Valentyna Lylo
  • Tetiana Ruban
  • Larysa Macewicz
  • Lyubov Lukash
Original Article

Abstract

The inducible repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) eliminates O6-methylguanine adducts in DNA and protects the cells from damaging effects of alkylating agents. We have found that anti-MGMT antibodies recognize both the MGMT protein with a mol. weight ~ 24 kDa and a protein with a mol. weight ~ 48 kDa, which was named MARP (anti-methyltransferase antibody recognizable protein). A number of growth factors and cytokines were shown to regulate the expression of MGMT and MARP proteins. The ranges of concentrations of several growth factors and cytokines that caused increasing or decreasing protein amounts in human cell cultures were determined. The results of special biological experiments have allowed us to assume a possible role of MARP in the repair of alkyl adducts in human cells.

Keywords

Cytokine DNA damage Repair enzyme MGMT Growth factor Antibody Human cells in vitro 

Notes

Acknowledgements

We are very grateful to Professors Korneluyk A.I., Kuchuk M.V., Drs. Chernykh S.I., Potopalsky A.I., and Luchakovskaya Yu.S. for providing the preparations of cytokines and alkylating agent.

Funding

The study was supported by the National Academy of Sciences of Ukraine (No. 0115U000355) and the Czech Research Infrastructure for Systems Biology C4SYS (Project No. LM2015055).

References

  1. Akopyan HR, Huleyuk NL, Kushniruk VO et al (2013) Comparative analysis of the karyotype of new human cell line 4BL at long-term cultivation: ploidy of the chromosomal set. Cytol Genet 47:305–317.  https://doi.org/10.3103/s0095452713050022 CrossRefGoogle Scholar
  2. Aldridge GM, Podrebarac DM, Greenough WT, Weiler IJ (2008) The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J Neurosci Methods 172:250–254CrossRefPubMedPubMedCentralGoogle Scholar
  3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefPubMedGoogle Scholar
  4. Briegert M, Enk AH, Kaina B (2007) Change in expression of MGMT during maturation of human monocytes into dendritic cells. DNA Repair 6:1255–1263CrossRefPubMedGoogle Scholar
  5. Buschfort-Papewalis C, Mortiz T, Liedert B, Thomale J (2002) Down-regulation of DNA repair in human CD34+ progenitor cells corresponds to increased drug sensitivity and apoptotic response. Blood 100:845–853CrossRefPubMedGoogle Scholar
  6. Cabrini G, Fabbri E, Lo Nigro C et al (2015) Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (review). Int J Oncol 47:417–428.  https://doi.org/10.3892/ijo.2015.3026 CrossRefPubMedPubMedCentralGoogle Scholar
  7. Cardozo AK, Kruhoffer M, Leeman R, Orntoft T, Eizirik DL (2001) Identification of novel cytokine-induced genes in pancreatic b-cells by high-density oligonucleotide arrays. Diabetes 50:909–920CrossRefPubMedGoogle Scholar
  8. Christmann M, Verbeek B, Roos WP, Kaina B (2011) O6-methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistry. Biochim Biophys Acta Rev Cancer 1816:179–190.  https://doi.org/10.1016/j.bbcan.2011.06.002 CrossRefGoogle Scholar
  9. Debili N, Masse J, Katz A et al (1993) Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells. Blood 82:84–95PubMedGoogle Scholar
  10. Eaton SL, Roche SL, Hurtado L, Oldknow KJ, Farquharson C, Gillingwater TH, Wishart TM (2013) Total protein analysis as a reliable loading control for quantitative fluorescent western blotting. PLoS ONE.  https://doi.org/10.1371/journal.pone.0072457 Google Scholar
  11. Frosina G, Laval F (1987) The O6-methylguanine-DNA-methyltransferase activity of rat hepatoma cells is increased after a single exposure to alkylating agents. Carcinogenesis 8:91–95CrossRefPubMedGoogle Scholar
  12. Gerson SL (2014) MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer 4:296–307CrossRefGoogle Scholar
  13. Gerson SL, Phillips W, Kastan M et al (1996) Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive O6-alkylguanine-DNA alkyltransferase and are sensitive to O6-benzylguanine plus BCNU. Blood 88:1649–1655PubMedGoogle Scholar
  14. Hermant B, Gudrun A, Potopalsky AI, Chroboczek J, Tcherniuk SO (2013) Amitozyn impairs chromosome segregation and induces apoptosis via mitotic checkpoint activation. PLoS ONE 8(3):e57461.  https://doi.org/10.1371/journal.pone.0057461 CrossRefPubMedGoogle Scholar
  15. Ishiguro K, Shyam K, Penketh PG, Baumann RP, Sartorelli AC, Rutherford TJ, Ratner ES (2013) Expression of O6-methylguanine-DNA methyltransferase examined by alkyl-transfer assays, methylation-specific PCR and western blots in tumors and matched normal tissue. J Cancer Ther 4:919–931CrossRefPubMedPubMedCentralGoogle Scholar
  16. Ivakhno SS, Kornelyuk AI (2004) Cytokine-like activities of some aminoacyl-tRNA synthetases and auxiliary p43 cofactor of aminoacylation reaction and their role in oncogenesis. Exp Oncol 26:250–255PubMedGoogle Scholar
  17. Jiang XB, Hu B, He DS, Mao ZG, Wang X, Song BB, Zhu YH, Wang HJ (2015) Expression profiling of O6-methylguanine-DNA-methyltransferase in prolactinomas: a correlative study of promoter methylation and pathological features in 136 cases. BMC Cancer.  https://doi.org/10.1186/s12885-015-1595-0 Google Scholar
  18. Kaina B, Fritz G, Ochs K, Haas S, Grombacher T, Dosch J, Christmann M, Lund P, Gregel CM, Becker K (1998) Transgenic systems in studies on genotoxicity of alkylating agents: critical lesions, thresholds and defense mechanisms. Mutat Res 405:179–191CrossRefPubMedGoogle Scholar
  19. Kaina B, Christmann M, Naumann S, Roos WP (2007) MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair 6:1079–1099CrossRefPubMedGoogle Scholar
  20. Klapacz J, Pottenger LH, Engelward BP et al (2016) Contributions of DNA repair and damage response pathways to the non-linear genotoxic responses of alkylating agents. Mutat Res Rev Mutat Res 767:77–91.  https://doi.org/10.1016/j.mrrev.2015.11.001 CrossRefPubMedGoogle Scholar
  21. Kohsaka S, Tanak S (2013) Chemotherapeutic agent for glioma. In: Clinical management and evolving novel therapeutic strategies for patients with brain tumors, vol 19. InTech, p 415–438.  https://doi.org/10.5772/45956
  22. Kotsarenko KV, Lylo VV, Macewicz LL, Ruban TP, Luchakivska YuS, Kuchuk MV, Lukash LL (2014) Influence of some biologically active substances on amount of MGMT and MARP proteins in human cells in vitro. Biopolym Cell 30:203–208CrossRefGoogle Scholar
  23. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685CrossRefPubMedGoogle Scholar
  24. Latypov VF, Tubbs JL, Watson AJ, Marriott AS, McGown G, Thorn-croft M, Wilkinson OJ, Senthong P, Butt A, Arvai AS, Millington CL, Povey AC, Williams DM, Santibanez-Koref MF, Tainer JA, Margison GP (2012) Atl1regulates choice between global genome and transcription-coupled repair of O(6)-alkylguanines. Mol Cell 47:50–60CrossRefPubMedPubMedCentralGoogle Scholar
  25. Lavon I, Fuchs D, Zrihan D, Efroni G, Zelikovitch B, Fellig Y, Siegal T (2007) Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O(6)-methylguanine-DNA-methyltransferase. Cancer Res 67:8952–8959CrossRefPubMedGoogle Scholar
  26. Lefebvre P, Laval F (1989) Potentiation of N-methyl-N′-nitro-N-nitrosoguanidine-induced O6-methylguanine-DNA-methyltransferase activity in a rat hepatoma cell line by poly (ADP-ribose) synthesis inhibitors. Biochem Biophys Res Commun 163:599–604CrossRefPubMedGoogle Scholar
  27. Lefebvre P, Zak P, Laval F (1993) Induction of O6-methylguanine-DNA-methyltransferase and N3-methyladenine-DNA-glycosylase in human cells exposed to DNA-damaging agents. DNA Cell Biol 12:233–241CrossRefPubMedGoogle Scholar
  28. Liu YJ (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23:275–306CrossRefPubMedGoogle Scholar
  29. Lukash LL, Boldt J, Pegg AE, Dolan ME, Maher VM, McCormic JJ (1991) Effect of O6-alkylguanine-DNA alkyltransferase on the frequency and spectrum of mutations induced by N-methyl-N′-nitro-N-nitrosoguanidine in the HPRT gene of diploid human fibroblasts. Mutat Res 250:397–409CrossRefPubMedGoogle Scholar
  30. Lylo VV, Macewicz LL, Kotsarenko KV, Babenko LA, Kornelyuk AI, Sukhorada EM, Lukash LL (2011) Activation of gene expression of the O6-methylguanine-DNA transferase repair enzyme upon the influence of EMAP II cytokine in human cells in vitro. Cytol Genet 45:373–378CrossRefGoogle Scholar
  31. Lylo VV, Karpova IS, Kotsarenko KV, Macewicz LL, Ruban TO, Lukash LL (2015) Lectins of Sambucus nigra in regulation of cellular DNA-protective mechanisms. Acta Hortic 1061:103–108CrossRefGoogle Scholar
  32. Macewicz LL, Kushniruk VO, Iatsyshyna AP, Kotsarenko KV, Lylo VV, Akopyan GR, Huleuk NL, Mykytenko DO, Lukash LL (2013) Correlation of mutagenesis level with expression of reparative enzyme O6-methylguanine-DNA methyltransferase during establishment of cell lines in vitro. Biopolym Cell 29:480–486CrossRefGoogle Scholar
  33. McDonald K, Tabone T, Nowak A, Erber W (2015) Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation. Oncol Lett.  https://doi.org/10.3892/ol.2015.2980 PubMedPubMedCentralGoogle Scholar
  34. Motomura K, Natsume A, Kishida Y, Higashi H, Kondo Y, Nakasu Y, Abe T, Namba H, Wakai K, Wakabayashi T (2011) Benefits of interferon-b and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter. Cancer 117:1721–1730CrossRefPubMedGoogle Scholar
  35. Natsume A, Ishii D, Wakabayashi T et al (2005) IFN-β down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res 65:7573–7579CrossRefPubMedGoogle Scholar
  36. Olson JJ, McKenzie E, Skurski-Martin M, Zhang Z, Brat D, Phuphanich S (2008) Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme. J Neurooncol 90:293–299CrossRefPubMedGoogle Scholar
  37. Park H, Park SG, Kim J, Ko YG, Kim S (2002) Signaling pathways for TNF production induced by human aminoacyl-tRNA synthetase-associating factor, p43. Cytokine 20:148–153CrossRefPubMedGoogle Scholar
  38. Park J-A, Joe Y-A, Kim T-G, Hong Y-K (2006) Potentiation of antiglioma effect with combined temozolomide and interferon-β. Oncol Rep.  https://doi.org/10.3892/or.16.6.1253 Google Scholar
  39. Pegg AE (2000) Repair of O6-alkylguanine by alkyltransferases. Mutat Res 462:83–100CrossRefPubMedGoogle Scholar
  40. Pegg AE (2011) Multifaceted roles of alkyltransferase and related proteins in DNA repair, DNA damage, resistance to chemotherapy, and research tools. Chem Res Toxicol 24:618–639CrossRefPubMedPubMedCentralGoogle Scholar
  41. Reznikov AG, Chaykovskaya LV, Polyakova LI et al (2011) Cooperative antitumor effect of endothelial-monocyte activating polypeptide II and flutamide on human prostate cancer xenografts. Exp Oncol 33:231–234PubMedGoogle Scholar
  42. Shen D, Guo C-C, Wang J et al (2015) Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells. Oncol Rep.  https://doi.org/10.3892/or.2015.4232 Google Scholar
  43. Stepanenko A, Andreieva S, Korets K, Mykytenko D, Baklaushev V, Huleyuk N, Kovalova O, Kotsarenko K, Chekhonin V, Vassetzky Y, Avdieiev S, Dmitrenko V (2016) Temozolomide promotes genomic and phenotypic changes in glioblastoma cells. Cancer Cell Int.  https://doi.org/10.1186/s12935-016-0311-8 PubMedPubMedCentralGoogle Scholar
  44. Thacker JS, Yeung DH, Staines WR, Mielke JG (2016) Total protein, or high abundance protein: which offers the best loading control for western blotting? Anal Biochem 496:76–78CrossRefPubMedGoogle Scholar
  45. Thomas AD, Jenkins GJS, Kaina B, Bodger OG, Tomaszowski KH, Lewis PD, Doak SH, Johnson GE (2013) Influence of DNA repair on nonlinear dose–responses for mutation. Toxicol Sci 132:87–95CrossRefPubMedPubMedCentralGoogle Scholar
  46. Thomas AD, Fahrer J, Johnson GE, Kaina B (2015) Theoretical considerations for thresholds in chemical carcinogenesis. Mutat Res Rev Mutat Res 765:56–67CrossRefPubMedGoogle Scholar
  47. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147CrossRefPubMedGoogle Scholar
  48. Tomaszowski KH, Aasland D, Margison GP, Williams E, Pinder SI, Modesti M, Fuchs RP, Kaina B (2015) The bacterial alkyltransferase-like (eATL) protein protects mammalian cells against methylating agent-induced toxicity. DNA Repair 28:14–20CrossRefPubMedGoogle Scholar
  49. Wang Y, Li J, Tohti M, Hu Y, Wang S, Li W, Lu Z, Ma C (2014) The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapy. J Exp Clin Cancer Res.  https://doi.org/10.1186/s13046-014-0056-y Google Scholar
  50. Wang X, Jia L, Jin X et al (2015) NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells. Oncol Lett 9:2586–2590.  https://doi.org/10.3892/ol.2015.3130 CrossRefPubMedPubMedCentralGoogle Scholar
  51. Zheng M, Bocangel D, Ramesh R, Ekmekcioglu S, Poindexter N, Grimm EA, Chada S (2008) Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells. Mol Cancer Ther 7:3842–3851CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Kateryna Kotsarenko
    • 1
  • Valentyna Lylo
    • 2
  • Tetiana Ruban
    • 2
  • Larysa Macewicz
    • 2
  • Lyubov Lukash
    • 2
  1. 1.University of South Bohemia in České BudějoviceCeske BudejoviceCzech Republic
  2. 2.Institute of Molecular Biology and Genetics of NAS of UkraineKievUkraine

Personalised recommendations